The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 36 | — | 20.1x | Near average | |
Growth | 77 | 23382.8% | 5.6% | Above average | |
Quality | 39 | -68.8% | 7.6% | Near average | |
Safety | 41 | 0.6x | 0.4x | Near average | |
Capital Return | 81 | — | 2.19% | Above average | |
Momentum | — | — | — | No data | |
Sentiment | — | — | — | No data |
Viridian Therapeutics, Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy Viridian Therapeutics, Inc. shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
VRDN stock experienced a slight decline in the average target price by 3.33% over the past thirty days, as the consensus dropped from 38.13 to 36.86 dollars despite the number of analysts covering the stock remaining constant. This downward adjustment reflects caution in short-term outlooks, although institutions such as RBC Capital and Wedbush maintained positive ratings (Outperform), suggesting that the change resulted from a re-evaluation of financial models rather than a fundamental shift in recommendation.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.